首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Phototherapy of posterior uveal melanomas.
【2h】

Phototherapy of posterior uveal melanomas.

机译:后葡萄膜黑色素瘤的光疗。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The results of phototherapy on a small series of 19 patients with uveal melanomas are presented. Laser radiation at a wavelength of 620 to 630 nm was used in conjunction with a 5 to 7.5 mg/kg dose of haematoporphyrin derivative administered 24 hours before treatment, with total doses/treatment averaging 960 J/cm2. Eleven patients received two treatments, and one received a third. The longest duration of tumour control to 30 September 1990 was 31 months. Of the 19 patients treated six had complete regression of the tumour, while another five had minor to significant regression. A strong correlation between degree of regression and degree of tumour pigmentation was found, the lighter tumours responding much better than darker tumours. There were also strong indications that if a tumour did not respond to the initial phototherapy it was very unlikely that subsequent phototherapy would provide any further benefit.
机译:介绍了19例葡萄膜黑色素瘤患者的光疗结果。在治疗前24小时给予620至630 nm波长的激光辐射和5至7.5 mg / kg剂量的血卟啉衍生物,总剂量/治疗平均为960 J / cm2。 11名患者接受了两种治疗,其中一种接受了第三种治疗。直到1990年9月30日,肿瘤控制时间最长为31个月。在接受治疗的19例患者中,有6例肿瘤完全消退,而另外5例则有轻度至明显消退。发现消退程度与肿瘤色素沉着程度之间存在很强的相关性,较轻的肿瘤比较黑的肿瘤有更好的反应。也有强有力的迹象表明,如果肿瘤对最初的光疗没有反应,那么随后的光疗将不太可能提供任何进一步的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号